Holguin A - Search Results

1

Trends in drug resistance prevalence in HIV-1-infected children in Madrid: 1993 to 2010 analysis.

de Mulder M, Yebra G, Navas A, Martin L, de Jose MI, Navarro ML, de Ory SJ, Gonzalez-Granado I, Mellado MJ, Ramos JT, Holguin A. de Mulder M, et al. Among authors: holguin a. Pediatr Infect Dis J. 2012 Nov;31(11):e213-21. doi: 10.1097/INF.0b013e3182678c7c. Pediatr Infect Dis J. 2012. PMID: 22785049

2

Increase of non-B subtypes and recombinants among newly diagnosed HIV-1 native Spaniards and immigrants in Spain.

Holguín A, de Mulder M, Yebra G, López M, Soriano V. Holguín A, et al. Curr HIV Res. 2008 Jun;6(4):327-34. doi: 10.2174/157016208785132455. Curr HIV Res. 2008. PMID: 18691031

3

Reliability of rapid subtyping tools compared to that of phylogenetic analysis for characterization of human immunodeficiency virus type 1 non-B subtypes and recombinant forms.

Holguín A, López M, Soriano V. Holguín A, et al. J Clin Microbiol. 2008 Dec;46(12):3896-9. doi: 10.1128/JCM.00515-08. Epub 2008 Oct 8. J Clin Microbiol. 2008. PMID: 18842935 Free PMC article.

4

Clinical differences and viral diversity between newly HIV type 1-diagnosed African and non-African patients in Spain (2005-2007).

Yebra G, Rivas P, Herrero MD, López M, de Mulder M, Puente S, Ramírez-Olivencia G, Soriano V, Holguín A. Yebra G, et al. Among authors: holguin a. AIDS Res Hum Retroviruses. 2009 Jan;25(1):37-44. doi: 10.1089/aid.2008.0134. AIDS Res Hum Retroviruses. 2009. PMID: 19182919

5

The maturation inhibitor bevirimat (PA-457) can be active in patients carrying HIV type-1 non-B subtypes and recombinants.

Yebra G, Holguín A. Yebra G, et al. Among authors: holguin a. Antivir Ther. 2008;13(8):1083-5. Antivir Ther. 2008. PMID: 19195334

6

[Epidemiology of drug-resistant HIV-1 transmission in naïve patients in Spain].

Yebra G, Holguín A. Yebra G, et al. Among authors: holguin a. Med Clin (Barc). 2010 Oct 16;135(12):561-7. doi: 10.1016/j.medcli.2009.09.029. Epub 2009 Dec 3. Med Clin (Barc). 2010. PMID: 19959197 Review. Spanish.

7

HIV-1 non-B subtypes: High transmitted NNRTI-resistance in Spain and impaired genotypic resistance interpretation due to variability.

Yebra G, de Mulder M, del Romero J, Rodríguez C, Holguín A. Yebra G, et al. Among authors: holguin a. Antiviral Res. 2010 Feb;85(2):409-17. doi: 10.1016/j.antiviral.2009.11.010. Epub 2009 Dec 11. Antiviral Res. 2010. PMID: 20004217

8

Sensitivity of seven HIV subtyping tools differs among subtypes/recombinants in the Spanish cohort of naïve HIV-infected patients (CoRIS).

Yebra G, de Mulder M, Martín L, Pérez-Cachafeiro S, Rodríguez C, Labarga P, García F, Tural C, Jaén A, Navarro G, Holguín A; Cohort of Spanish AIDS Research Network (CoRIS). Yebra G, et al. Among authors: holguin a. Antiviral Res. 2011 Jan;89(1):19-25. doi: 10.1016/j.antiviral.2010.10.008. Epub 2010 Nov 9. Antiviral Res. 2011. PMID: 21070813

9

Drug resistance prevalence in human immunodeficiency virus type 1 infected pediatric populations in Honduras and El Salvador during 1989-2009.

Holguín A, Erazo K, Escobar G, de Mulder M, Yebra G, Martín L, Jovel LE, Castaneda L, Pérez E; Proyecto Esther. Holguín A, et al. Pediatr Infect Dis J. 2011 May;30(5):e82-7. doi: 10.1097/INF.0b013e3182117289. Pediatr Infect Dis J. 2011. PMID: 21326132

10

Mutation Vif-22H, which allows HIV-1 to use the APOBEC3G hypermutation to develop resistance, could appear more quickly in certain non-B variants.

Yebra G, Holguín A. Yebra G, et al. Among authors: holguin a. J Antimicrob Chemother. 2011 Apr;66(4):941-2. doi: 10.1093/jac/dkr012. Epub 2011 Feb 3. J Antimicrob Chemother. 2011. PMID: 21393191 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

221 results

Search Page

Filters